Overexpression of miR-32 in Chinese hamster ovary cells increases production of Fc-fusion protein

[1]  M. Soleimani,et al.  Recent developments in miRNA based recombinant protein expression in CHO , 2022, Biotechnology Letters.

[2]  Alana C Szkodny,et al.  Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions. , 2022, Annual review of chemical and biomolecular engineering.

[3]  M. Andersen,et al.  Identification of novel miRNA targets in CHO cell lines and characterization of their impact on protein N-glycosylation , 2022 .

[4]  D. Weinberger,et al.  Aflibercept clearance through the drainage system in a rat model , 2021, International Journal of Retina and Vitreous.

[5]  Yongfeng Hui,et al.  miR-32-5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1 , 2021, Molecular medicine reports.

[6]  Vladimir Benes,et al.  Web-based LinRegPCR: application for the visualization and analysis of (RT)-qPCR amplification and melting data , 2021, BMC Bioinformatics.

[7]  Chi Zhou,et al.  miR-32-5p Inhibits the Proliferation, Migration and Invasion of Thyroid Cancer Cells by Regulating Twist1 , 2021 .

[8]  Asher Mullard.  FDA approves 100th monoclonal antibody product , 2021, Nature Reviews Drug Discovery.

[9]  J. Kalinowski,et al.  Exploring the molecular content of CHO exosomes during bioprocessing , 2021, Applied Microbiology and Biotechnology.

[10]  H. Xiong,et al.  Roles of BTLA in Immunity and Immune Disorders , 2021, Frontiers in Immunology.

[11]  Shikai Liu,et al.  MicroRNA-32 promotes ovarian cancer cell proliferation and motility by targeting SMG1 , 2020, Oncology letters.

[12]  M. Butler,et al.  Mammalian cell culture for production of recombinant proteins: A review of the critical steps in their biomanufacturing. , 2020, Biotechnology advances.

[13]  L.-M. Wang,et al.  Overexpression of miR-32 inhibits the proliferation and metastasis of ovarian cancer cells by targeting BTLA. , 2020, European review for medical and pharmacological sciences.

[14]  P. Shamlou,et al.  Inhibition of endogenous miR‐23a/miR‐377 in CHO cells enhances difficult‐to‐express recombinant lysosomal sulfatase activity , 2020, Biotechnology progress.

[15]  Z. Du,et al.  High throughput, efficacious gene editing & genome surveillance in Chinese hamster ovary cells , 2019, PloS one.

[16]  Buchang Zhang,et al.  MiR-106b promotes therapeutic antibody expression in CHO cells by targeting deubiquitinase CYLD , 2019, Applied Microbiology and Biotechnology.

[17]  M. Rajabibazl,et al.  Development of an improved lentiviral based vector system for the stable expression of monoclonal antibody in CHO cells , 2019, Preparative biochemistry & biotechnology.

[18]  H. Chen,et al.  MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma , 2019, Technology in cancer research & treatment.

[19]  Vaibhav Jadhav,et al.  CRISPR/Cas9-Mediated Knockout of MicroRNA-744 Improves Antibody Titer of CHO Production Cell Lines. , 2019, Biotechnology journal.

[20]  L. Chen,et al.  MicroRNA-32 inhibits the proliferation, migration and invasion of human colon cancer cell lines by targeting E2F transcription factor 5. , 2019, European review for medical and pharmacological sciences.

[21]  M. Andersen,et al.  CRISPR/Cas9-Multiplexed Editing of Chinese Hamster Ovary B4Gal-T1, 2, 3, and 4 Tailors N-Glycan Profiles of Therapeutics and Secreted Host Cell Proteins. , 2018, Biotechnology journal.

[22]  J. Andersen,et al.  Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding properties , 2018, Scientific Reports.

[23]  J. Shiloach,et al.  Methods for Using Small Non-Coding RNAs to Improve Recombinant Protein Expression in Mammalian Cells , 2018, Genes.

[24]  A. Wagner,et al.  miR‐143 targets MAPK7 in CHO cells and induces a hyperproductive phenotype to enhance production of difficult‐to‐express proteins , 2017, Biotechnology progress.

[25]  Carlo M. Croce,et al.  Small non-coding RNA and cancer , 2017, Carcinogenesis.

[26]  W. P. Loh,et al.  miR-92a enhances recombinant protein productivity in CHO cells by increasing intracellular cholesterol levels. , 2017, Biotechnology journal.

[27]  W. Xia,et al.  MicroRNA-32 promotes cell proliferation, migration and suppresses apoptosis in breast cancer cells by targeting FBXW7 , 2017, Cancer Cell International.

[28]  P. Khaw,et al.  Fc-fusion mimetics. , 2016, Biomaterials science.

[29]  A. Sczyrba,et al.  miRNA profiling of high, low and non-producing CHO cells during biphasic fed-batch cultivation reveals process relevant targets for host cell engineering. , 2016, Journal of biotechnology.

[30]  S. Kochanek,et al.  Temperature‐sensitive miR‐483 is a conserved regulator of recombinant protein and viral vector production in mammalian cells , 2016, Biotechnology and bioengineering.

[31]  Lei Li,et al.  miR-32 inhibits proliferation, epithelial–mesenchymal transition, and metastasis by targeting TWIST1 in non-small-cell lung cancer cells , 2016, OncoTargets and therapy.

[32]  Yong Peng,et al.  The role of MicroRNAs in human cancer , 2016, Signal Transduction and Targeted Therapy.

[33]  Simon Fischer,et al.  The art of CHO cell engineering: A comprehensive retrospect and future perspectives. , 2015, Biotechnology advances.

[34]  Simon Fischer,et al.  Enhanced protein production by microRNA-30 family in CHO cells is mediated by the modulation of the ubiquitin pathway. , 2015, Journal of biotechnology.

[35]  Zhefu Ma,et al.  MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[36]  C. Gallagher,et al.  Re-programming CHO cell metabolism using miR-23 tips the balance towards a highly productive phenotype. , 2015, Biotechnology journal.

[37]  C. Gallagher,et al.  Conserved microRNA function as a basis for Chinese hamster ovary cell engineering , 2015, Biotechnology Letters.

[38]  Yu-Qin Wang,et al.  MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN , 2015, Tumor Biology.

[39]  Alexandra B. Graf,et al.  Identification of microRNAs specific for high producer CHO cell lines using steady-state cultivation , 2014, Applied Microbiology and Biotechnology.

[40]  Weibin Zhang,et al.  RETRACTED ARTICLE: MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9 , 2014, Tumor Biology.

[41]  Vaibhav Jadhav,et al.  Stable overexpression of miR-17 enhances recombinant protein production of CHO cells☆ , 2014, Journal of biotechnology.

[42]  Jeffry D. Sander,et al.  CRISPR-Cas systems for editing, regulating and targeting genomes , 2014, Nature Biotechnology.

[43]  David P. Kreil,et al.  CHO microRNA engineering is growing up: Recent successes and future challenges☆ , 2013, Biotechnology advances.

[44]  Yih Yean Lee,et al.  Identification and expression analysis of miRNAs during batch culture of HEK-293 cells. , 2009, Journal of biotechnology.

[45]  Niraj Kumar,et al.  Initial identification of low temperature and culture stage induction of miRNA expression in suspension CHO-K1 cells. , 2007, Journal of biotechnology.

[46]  Niraj Kumar,et al.  Proliferation control strategies to improve productivity and survival during CHO based production culture , 2007, Cytotechnology.

[47]  Zhiwei Song,et al.  RNAi suppression of Bax and Bak enhances viability in fed-batch cultures of CHO cells. , 2006, Metabolic engineering.

[48]  G. Yancopoulos,et al.  VEGF-Trap: A VEGF blocker with potent antitumor effects , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Danni Qu,et al.  MiR-32-5p regulates the proliferation and metastasis of cervical cancer cells by targeting HOXB8. , 2019, European review for medical and pharmacological sciences.

[50]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..